These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21708441)

  • 1. Noncontrast chest computed tomography immediately after transarterial chemoembolization in patients with hepatocellular carcinoma: clinical benefits and effect of radiation reduction on image quality in low-dose scanning.
    Choi JI; Kim HB; Kim MJ; Lee JS; Koh YW; An SB; Ko HK; Park JW
    Eur J Radiol; 2011 Nov; 80(2):e188-94. PubMed ID: 21708441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads.
    Golowa YS; Cynamon J; Reinus JF; Kinkhabwala M; Abrams M; Jagust M; Chernyak V; Kaubisch A
    J Vasc Interv Radiol; 2012 Aug; 23(8):1031-5. PubMed ID: 22739645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma.
    Takayasu K; Arii S; Matsuo N; Yoshikawa M; Ryu M; Takasaki K; Sato M; Yamanaka N; Shimamura Y; Ohto M
    AJR Am J Roentgenol; 2000 Sep; 175(3):699-704. PubMed ID: 10954453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma.
    Iwazawa J; Ohue S; Kitayama T; Sassa S; Mitani T
    AJR Am J Roentgenol; 2011 Aug; 197(2):W337-42. PubMed ID: 21785062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitation of Virtual Noncontrasted Images in Evaluation of a Liver Lesion Status Post Transarterial Chemoembolization.
    Flemming BP; De Cecco CN; Hardie AD
    J Comput Assist Tomogr; 2016; 40(4):557-9. PubMed ID: 27023858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
    Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
    Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization for hepatocellular carcinomas in watershed segments: utility of C-arm computed tomography for treatment planning.
    Abdelmaksoud MH; Louie JD; Hwang GL; Sze DY; Hofmann LV; Kothary N
    J Vasc Interv Radiol; 2012 Feb; 23(2):281-3. PubMed ID: 22264556
    [No Abstract]   [Full Text] [Related]  

  • 10. Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?
    Hui TC; Pua U
    J Vasc Interv Radiol; 2014 Jan; 25(1):41-6. PubMed ID: 24290098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
    Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
    J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization.
    Kakeda S; Korogi Y; Ohnari N; Moriya J; Oda N; Nishino K; Miyamoto W
    J Vasc Interv Radiol; 2007 Dec; 18(12):1508-16. PubMed ID: 18057285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors.
    Park SH; Cho YK; Ahn YS; Park YO; Kim JK; Chung JW
    Korean J Radiol; 2007; 8(2):111-9. PubMed ID: 17420628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
    Liu QY; He CD; Zhou Y; Huang D; Lin H; Wang Z; Wang D; Wang JQ; Liao LP
    World J Gastroenterol; 2016 Mar; 22(11):3242-51. PubMed ID: 27004002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
    Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
    J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of the previous serial CT images.
    Jang KM; Choi D; Lim HK; Lim JH; Lee JY; Lee WJ; Kim SH; Lee SJ; Jeon YH; Lee J; Kim MJ; Shin SW; Park CK
    Korean J Radiol; 2005; 6(3):153-60. PubMed ID: 16145290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization.
    Koh YH; Choi JI; Kim HB; Kim MJ
    Korean J Radiol; 2013; 14(5):733-42. PubMed ID: 24043966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma.
    Iwazawa J; Ohue S; Hashimoto N; Muramoto O; Mitani T
    Eur J Radiol; 2012 Dec; 81(12):3985-92. PubMed ID: 22959287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.